Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Melanoma Institute Australia
Chinese PLA General Hospital
M.D. Anderson Cancer Center
BioInvent International AB
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Spanish Oncology Genito-Urinary Group
Leiden University Medical Center
ImmunSYS, LLC
Rampart Health, L.L.C.
Massachusetts General Hospital